Company / Profit Margin
Stoke Therapeutics, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3.7%
FY2025
5-year range
-1192.5% / -3.7%
FY2022-FY2025
Trend
+99.7%
vs FY2024
Sector context
#61 of 146
Health Care
What the data says
At -3.7%, Stoke Therapeutics, Inc.'s profit margin ranks #61 of 146 in the Health Care sector. Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -3.7%.
Based on SEC 10-K filings.
-3.7% in FY2025 with a 3-year CAGR of +688.0%.
Improved from -814.7% to -3.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +688.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#61 of 146 in Health CareTop 42% of 146This company -3.7% Sector average -796.3%
▼
+99.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 99.7% year-over-year.
- Currently 792.5pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.7% | +99.7% |
| FY2024 | -1192.5% | -46.4% |
| FY2023 | -814.7% | -17.8% |
| FY2022 | -691.7% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026